Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
University of Chicago
Shanghai Zhongshan Hospital
University Hospital, Lille
Xijing Hospital
Fudan University
Fundación Sociedad Española de Oncologia Médica
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
National Cancer Center, Korea
Krankenhaus Nordwest
Xijing Hospital
Peking University
Jagiellonian University
Centre Hospitalier Universitaire Vaudois
Ruijin Hospital
Mario Negri Institute for Pharmacological Research
The Second Affiliated Hospital of Fujian Medical University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Corporacion Parc Tauli
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Karolinska Institutet
ChineseAMS
Qilu Hospital of Shandong University
Zhejiang Cancer Hospital
Wuhan University
M.D. Anderson Cancer Center
ChineseAMS
Peking University Third Hospital
Peking University
Wake Forest University Health Sciences
Peking University
Sun Yat-sen University
NYU Langone Health
University of Campania Luigi Vanvitelli
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Zhejiang Cancer Hospital
Soonchunhyang University Hospital
University of Southern California
Zhejiang Cancer Hospital
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Soroka University Medical Center